DOI: 10.36347/sjams.2022.v10i03.010

Pages: 331-335

COVID-19 pandemic is caused by highly infectious SARS-CoV-2. Observational studies have documented several neurological complications or associations either during or after the COVID-19. Some of them, have reported some case reports regarding COVID-19 in patients with a known history of myasthenia gravis (MG) but new onset of autoimmune MG in patients with COVID-19 is scarcely reported. Here, we report two novel cases of new-onset autoimmune MG following COVID-19 and describe the clinical and paraclinical findings in the context of other scarce reported cases.